These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3926024)

  • 1. Minactivin expression in human monocyte and macrophage populations.
    Stephens RW; Golder JP; Fayle DR; Hume DA; Hapel AJ; Allan W; Fordham CJ; Doe WF
    Blood; 1985 Aug; 66(2):333-7. PubMed ID: 3926024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minactivin: a human monocyte product which specifically inactivates urokinase-type plasminogen activators.
    Golder JP; Stephens RW
    Eur J Biochem; 1983 Nov; 136(3):517-22. PubMed ID: 6416839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel properties of human monocyte plasminogen activator.
    Stephens RW; Golder JP
    Eur J Biochem; 1984 Mar; 139(2):253-8. PubMed ID: 6199200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proenzyme to urokinase-type plasminogen activator in human colon cancer: in vitro inhibition by monocyte minactivin after proteolytic activation.
    Stephens RW; Fordham CJ; Doe WF
    Eur J Cancer Clin Oncol; 1987 Feb; 23(2):213-22. PubMed ID: 2965017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly-D-lysine dependent inactivation of tissue plasminogen activator by a class PAI-2 inhibitor (minactivin).
    Leung KC; Byatt JA; Stephens RW
    Thromb Res; 1987 Jun; 46(6):767-77. PubMed ID: 3114909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The resistance of fibrin-stimulated tissue plasminogen activator to inactivation by a class PAI-2 inhibitor (minactivin).
    Leung KC; Byatt JA; Stephens RW
    Thromb Res; 1987 Jun; 46(6):755-66. PubMed ID: 2957818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activation and regulation of pericellular proteolysis.
    Saksela O
    Biochim Biophys Acta; 1985 Nov; 823(1):35-65. PubMed ID: 2413894
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased synthesis of fibrinolytic inhibitor induced by muramyl dipeptide derivatives in human cultured endothelial cells.
    Dosne AM; Dubor F; Terrier M; Dupuy E; Chedid L
    Int J Immunopharmacol; 1985; 7(2):225-30. PubMed ID: 3924845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of polymyxin B and colimycin on induction of plasminogen antiactivator by lipopolysaccharide in human endothelial cell culture.
    Dubor F; Dosne AM; Chedid LA
    Infect Immun; 1986 Jun; 52(3):725-9. PubMed ID: 3011672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage fibrinolytic activity: identification of two pathways of plasmin formation by intact cells and of a plasminogen activator inhibitor.
    Chapman HA; Vavrin Z; Hibbs JB
    Cell; 1982 Mar; 28(3):653-62. PubMed ID: 6210439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activator-specific inhibitors in mouse macrophages: in vivo and in vitro modulation of their synthesis and secretion.
    Wohlwend A; Belin D; Vassalli JD
    J Immunol; 1987 Aug; 139(4):1278-84. PubMed ID: 3112228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of plasminogen activator activity in arthritic joints.
    Hamilton JA; Hart PH; Leizer T; Vitti GF; Campbell IK
    J Rheumatol Suppl; 1991 Feb; 27():106-9. PubMed ID: 1902874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of human bone marrow-derived macrophages.
    Hume DA; Allan W; Golder J; Stephens RW; Doe WF; Warren HS
    J Leukoc Biol; 1985 Oct; 38(4):541-52. PubMed ID: 3928788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activator-specific inhibitors produced by human monocytes/macrophages.
    Wohlwend A; Belin D; Vassalli JD
    J Exp Med; 1987 Feb; 165(2):320-39. PubMed ID: 2434595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation-linked secretion of urokinase and tissue plasminogen activator by normal human hemopoietic cells.
    Wilson EL; Francis GE
    J Exp Med; 1987 Jun; 165(6):1609-23. PubMed ID: 3108448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression by U-937 mononuclear phagocytes. Effects of 1 alpha, 25-dihydroxyvitamin D3 and phorbol ester.
    Gyetko MR; Webb AC; Sitrin RG
    J Immunol; 1988 Oct; 141(8):2693-8. PubMed ID: 3139763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of expression of monocyte/macrophage plasminogen activator activity and its implications for attenuation of vasculopathy.
    Lundgren CH; Sawa H; Sobel BE; Fujii S
    Circulation; 1994 Oct; 90(4):1927-34. PubMed ID: 7923681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activator production by bovine milk macrophages and blood monocytes.
    Politis I; Zhao X; McBride BW; Burton JH; Turner JD
    Am J Vet Res; 1991 Aug; 52(8):1208-13. PubMed ID: 1928901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the catalytic activity of plasminogen activator under physiologic conditions.
    Aggeler J; Risch J; Werb Z
    Biochim Biophys Acta; 1981 Jun; 675(1):62-8. PubMed ID: 6455162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activator secreted by cultured human melanocytes.
    Hashimoto K; Horikoshi T; Nishioka K; Yoshikawa K; Carter DM
    Br J Dermatol; 1986 Aug; 115(2):205-9. PubMed ID: 3091061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.